Synthetic Biologics Inc (SYN)

1.4500
-0.1200(-7.64%)
After Hours
1.4600
+0.0200(+1.3889%)
- Real-time Data
  • Volume:
    513,173
  • Day's Range:
    1.3800 - 1.5000
  • 52 wk Range:
    0.4998 - 5.5750
Unusual trading volume

SYN Overview

Prev. Close
1.57
Day's Range
1.38-1.5
Revenue
-
Open
1.48
52 wk Range
0.4998-5.575
EPS
-1.2
Volume
513,173
Market Cap
22.97M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
171,828
P/E Ratio
-
Beta
-
1-Year Change
-70.99%
Shares Outstanding
15,844,123
Next Earnings Date
Aug 11, 2022
What is your sentiment on Synthetic Biologics?
or
Market is currently closed. Voting is open during market hours.

Synthetic Biologics Inc News

Welcome to Your News Upgrade

Be the First to Know and Act on Market Moving News.

Welcome to Your News Upgrade

Synthetic Biologics Inc Analysis

Synthetic Biologics Inc Company Profile

Synthetic Biologics Inc Company Profile

Employees
16

Synthetic Biologics, Inc. is a clinical-stage company. The Company is engaged in developing therapeutics designed to treat gastrointestinal (GI) diseases. The Company's lead product candidates in Phase III development are SYN-004 (ribaxamase) which is designed to degrade certain commonly used intravenous (IV) beta-lactam antibiotics within the GI tract to prevent microbiome damage, and acute graft-versus-host-disease (aGVHD) in allogeneic hematopoietic cell transplant recipients, and Phase II SYN-010 which reduce methane-producing organisms in the gut microbiome to treat an underlying cause of irritable bowel syndrome with constipation. The Company also develops an oncolytic adenovirus (OV) platform designed to trigger tumor cell death and promote immune cell infiltration into tumors. Its lead product, VCN-01, is an oncolytic adenovirus with characteristics being studied in clinical trials for cancers for which there is no cure, including pancreatic carcinoma and retinoblastoma.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellStrong SellNeutralStrong SellStrong Sell
Technical IndicatorsStrong SellStrong BuyStrong SellStrong SellStrong Sell
SummaryStrong SellStrong SellSellStrong SellStrong Sell
  • very huge volume. four time average Volume. maybe something will happen here.
    0
    • future glossy stock
      0
  • all Americans company go down.
    0
    • Fool
      0
  • bought stock today lets see will wait 1 month to see it hit a $1
    0
    • anyone know something about this value why didn't it just go up?
      0
      • bought some shares today at 0.7222 slightly under water but if the after market is real might already be green  anyway - seems like a great company at a discount amazing products if anybody wants to check it out  https://www.syntheticbiologics.com
        1
        • I think the same. I think it will go back to the real price again
          0
      • we will hit 1$ soon
        0
        • hmmm strange. whats going on here, yesterdays volume 117 M ? more than nio, that cant be. can someone explain that high volume?
          0
          • Upgraded to buy
            0
        • @michael radey, i did not panic sell. still own all my shares since 2016 with a 99percent loss. are you that happy too after the next reverse split? lol. why are you so desperately promoting this stock? :)
          2
          • Cause I’m the CEO
            0
        • Hope yall didnt panic sell like Thomas Brunner!
          1
          • Lollllll a good one
            0
          • sorry i didnt get the joke. i guess all people who lost a lot since 2016 on this stock also dont find it funny. are you the ceo of this company, is that why are so hard pushing this stock?
            0
        • This company had a share price of 100 usd in 2015, they crashed hard in 2016 and have been struggling ever since. I do not think it's an investment for the short term. however in the next several months to a year I expect a slight recovery.
          0
          • honestly, i wish that this company succeed and release finally a product and make money. but i am very sceptical.
            0